Evidence search
Evidence search for the S3 guideline on peri- and postmenopause - diagnostics and interventions
Report documents
-
Evidence report
V24-05A: Cognitive behavioural therapy: Evidence report for the S3 guideline on peri- and postmenopause - diagnostics and interventions
-
Evidence report
V24-05B: Isoflavone: Evidence report for the S3 guideline on peri- and postmenopause - diagnostics and interventions
-
Evidence report
V24-05C: Cimicifuga: Evidence report for the S3 guideline on peri- and postmenopause - diagnostics and interventions
-
Evidence report
V24-05D: SSRI/SSNRI: Evidence report for the S3 guideline on peri- and postmenopause - diagnostics and interventions
-
Evidence report
V24-05E: Clonidine: Evidence report for the S3 guideline on peri- and postmenopause - diagnostics and interventions
-
Evidence report
V24-05F: Gabapentin: Evidence report for the S3 guideline on peri- and postmenopause - diagnostics and interventions
Project details
- Project no.
- V24-05
- Commission
- Commission awarded on 16.05.2024 by the Federal Ministry of Health (BMG).
- Report type
- Evidence search
- Status
- Commission completed
- Department/Division
- Health Care and Guidelines
- Topic
- DMP and clinical pratice guidelines
- Note
-
The search for evidence on the S3 guideline on peri- and postmenopause - diagnostics and interventions covers 6 evidence reports.
- DOI
https://doi.org/10.60584/V24-05A: Cognitive behavioural therapy: Evidence report for the S3 guideline on peri- and postmenopause - diagnostics and interventions (V24-05A)
https://doi.org/10.60584/V24-05B: Isoflavone: Evidence report for the S3 guideline on peri- and postmenopause - diagnostics and interventions (V24-05B)
https://doi.org/10.60584/V24-05C: Cimicifuga: Evidence report for the S3 guideline on peri- and postmenopause - diagnostics and interventions (V24-05C)
https://doi.org/10.60584/V24-05D: SSRI/SSNRI: Evidence report for the S3 guideline on peri- and postmenopause - diagnostics and interventions (V24-05D)
https://doi.org/10.60584/V24-05E: Clonidine: Evidence report for the S3 guideline on peri- and postmenopause - diagnostics and interventions (24-05E)
https://doi.org/10.60584/V24-05F: Gabapentin: Evidence report for the S3 guideline on peri- and postmenopause - diagnostics and interventions (V24-05F)